Cannabis News
Want to Get an Extra Half-Hour of Sleep Every Night?
Published
2 years agoon
By
admin
A groundbreaking study conducted by researchers from the University of Auckland in New Zealand has unveiled a potentially remarkable medical benefit of the mystical and potent hallucinogen lysergic acid diethylamide (LSD): its ability to enhance sleep. Titled “LSD Increases Sleep Duration the Night After Microdosing,” the study was published on June 28.
The findings revealed a significant improvement in sleep patterns, albeit with a delayed effect that manifested the day after the initial LSD experience had subsided.
The researchers carefully followed a group of 80 healthy adult male volunteers for the study over a period of six weeks. Every third day, self-administered doses of either a 10 g microdose of LSD or a placebo were given to these volunteers. Due to the tolerance building up to LSD’s effects, which normally last for two to three consecutive days as documented by MAPS, this dose regimen was consciously chosen.
The study concentrated on LSD microdoses, which are substantially smaller than the average recreational dose range of 50-250 g. Nonetheless, even at this lower dose, LSD had a more powerful effect than other hallucinogens.
Surprisingly, the researchers saw that the sleep patterns the next day had improved in a “clinically significant” way, including a rise in the amount of time spent in REM sleep. The most common stage of sleep, known as REM sleep, is when dreams typically take place.
Benefit of a Better Sleep Time
The researchers noted that participants who took a microdose of LSD the day before experienced significantly increased sleep duration compared to those in the placebo group. However, no differences in sleep were observed on the actual dosing day. The differences translated to an additional 8 minutes of REM sleep, 21 minutes of overall sleep time, and 24 minutes of total sleep time on the night following microdosing. Interestingly, participants in the LSD group went to bed earlier on the night after microdosing.
The study was authored by Nathan Allen, Aron Jeremiah, Robin Murphy, Rachael Sumner, Anna Forsyth, Nicholas Hoeh, David B Menkes, William Evans, Suresh Muthukumaraswamy, Frederick Sundram, and Partha Roop.
Furthermore, the authors highlighted that there were no differences in the distribution of sleep stages or physical activity between the LSD and placebo groups, nor any evidence of tolerance or altered sensation.
The researchers stressed the substantial implications of microdosing substances like LSD or psilocybin in the field of psychotherapy, delivered below the threshold for causing hallucinations. These consequences include improved mood and well-being, relief from anxiety and depression symptoms, and maybe increased creativity and productivity.
To monitor sleep duration throughout the study, a commercially available sleep/activity tracker was utilized. Analysis of sleep data from multiple nights demonstrated that participants in the LSD group slept an average of 24.3 minutes longer per night than those in the placebo group on the night following microdosing. No reductions in sleep were observed on the actual dosing day itself.
Implications for LSD in Medicine
The findings of this study reveal significant alterations in the physiological sleep requirements of healthy individuals who engage in microdosing. These findings have potential implications for the therapeutic effects of microdosing in mood disorders, specifically major depressive disorder, where sleep disturbances are commonly experienced. The objectively measured changes in sleep observed are distinct and clinically significant, making it difficult to attribute them to a mere placebo effect.
The authors acknowledged that previous microdosing studies have provided subjective reports regarding sleep quality. These studies have shown mixed results, with some participants reporting improvements in sleep while others experienced difficulties.
Furthermore, these findings are consistent with the positive sleep responses reported by MindBio Therapeutics earlier this month. Their study involved 80 participants in a clinical trial who were administered either a microdose of LSD or a placebo.
Additionally, in 2022, a New York-based biotech firm initiated a clinical trial to investigate the potential of LSD as a treatment for anxiety.
Unlocking LSD’s Therapeutic Potential: Exploring Promising Effects
The study’s results shed light on the intriguing therapeutic potential of LSD in the realm of medicine, particularly in addressing mood disorders and sleep disturbances. The significant changes observed in sleep patterns following microdosing suggest that LSD could offer valuable benefits for individuals struggling with conditions like major depressive disorder, where disrupted sleep is a common issue.
By extending sleep duration and enhancing REM sleep, LSD microdoses hold the promise of positively influencing mood and overall well-being. Given the crucial role of sleep in emotional regulation, the ability of LSD to improve sleep could potentially alleviate symptoms of depression and anxiety associated with these disorders.
Importantly, the objective measurements used in this study provide robust evidence beyond subjective reports, making it difficult to attribute the observed changes solely to a placebo effect. The clinically significant findings further reinforce the potential of LSD as a therapeutic agent.
These encouraging outcomes pave the way for continued research and exploration of LSD’s therapeutic potential. Ongoing studies and clinical trials, including the notable work by MindBio Therapeutics, are actively investigating the broader applications of LSD in treating various mental health conditions.
As our knowledge of LSD expands, it creates new opportunities for cutting-edge therapeutic techniques. With its emphasis on sub-threshold doses that maximize benefits while limiting hallucinogenic effects, microdosing has potential for boosting innovation, productivity, and general mental health.
While more research is needed to completely understand the underlying processes of LSD’s therapeutic effects, these findings lay a solid platform for future investigation. They underscore LSD’s potential as a significant medical tool, providing hope to patients seeking alternative therapies for mood disorders and sleep-related issues.
Bottom Line
The groundbreaking study conducted by researchers from the University of Auckland provides compelling evidence for the potential of microdoses of LSD in enhancing sleep duration and improving sleep patterns, particularly in individuals with mood disorders. The significant objective measurements of increased sleep time and improved REM sleep bolster the case for LSD’s therapeutic effects, surpassing placebo expectations. These findings offer new avenues for exploration and underscore the potential of LSD microdosing as a promising approach to alleviate sleep disturbances and enhance overall well-being in individuals grappling with mood disorders. Further research in this area holds great promise for advancing our understanding and utilization of LSD’s therapeutic potential in the realm of mental health.
MICRODOSING LSD, WHAT’S UP? READ ON….
You may like
-
Couple arrested with large amounts of weed and molly
-
The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!
-
Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place
-
Oklahoma voters could weigh in on adult-use marijuana legalization in 2026
-
Karma Koala Podcast 247: Speaking with Dr. Natalie Corthésy senior lecturer university of West Indies & Enrico Bonadio professor of law City St George’s University of London about their forthcoming Edward Elgar title, “Intellectual Property and Cannabis”
-
MJBizCon offers speakers chance to share cannabis insights, shape industry
Cannabis News
The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!
Published
20 hours agoon
April 5, 2025By
admin
The Rescheduling Ruse: Why I Told You So
In a move that surprised absolutely no one who’s been paying attention, the White House recently announced it has “no action planned” on marijuana reform. Yes, the same marijuana reform that President Trump enthusiastically backed on the campaign trail just weeks before Election Day.
The writing was on the wall all along, folks. I’ve been telling you for months that the much-hyped rescheduling of cannabis from Schedule I to Schedule III was nothing more than political theater – a carefully choreographed dance designed to generate headlines without delivering substantive change. And here we are, with yet another administration putting cannabis reform on the back burner while millions of Americans continue to live under the shadow of failed prohibition policies.
Don’t get me wrong – I’m not here to play political favorites. This isn’t a red versus blue issue. The Biden administration dangled the same carrot, initiating a rescheduling process that conveniently stalled due to “complications” with DEA hearings. Different players, same game.
Let’s take a step back and examine what’s really happening here, because the truth about cannabis reform in America is both simpler and more complex than most people realize.
Trump’s pre-election cannabis conversion was quite the spectacle, wasn’t it? Suddenly, the man who selected Jeff “Good People Don’t Smoke Marijuana” Sessions as his first Attorney General was voicing support for rescheduling, banking access, and even Florida’s legalization initiative.
But as CNN recently reported, “no action is being considered at this time.” The honeymoon didn’t even last through the first dance. The administration’s priorities lie elsewhere – immigration, government spending, foreign policy – while cannabis reform gets shelved alongside countless other campaign promises.
Interestingly, CNN did note that Trump and his transition team attempted to include cannabis banking protections in December’s government funding resolution. This behind-the-scenes effort suggests at least some genuine interest in the issue, but hardly qualifies as the bold reform millions of voters were led to expect.
This pattern should feel familiar. The Biden administration made similar overtures, with the president announcing pardons for federal marijuana possession offenses and directing an administrative review of cannabis scheduling. That process dragged on for over a year, with the DEA repeatedly delaying final action. Biden got the headlines; cannabis users got nothing.
The harsh reality? Cannabis reform makes for good campaign fodder, but terrible governance priorities. Once elected, the political calculus changes dramatically. The motivation to deliver evaporates when the votes are already counted and the special interests start calling in their favors.
At the heart of this perpetual delay lies the Drug Enforcement Administration – an agency whose very existence depends on the continuation of the drug war. Expecting the DEA to facilitate cannabis reform is like asking a turkey to vote for Thanksgiving.
The DEA has mastered the art of procedural obstruction. Under Biden, they scheduled hearings, requested extensions, and effectively ran out the clock. Under Trump, they appear poised to do absolutely nothing, perhaps not even bothering with the pretense of consideration.
The pattern becomes clearer when you look at Trump’s cabinet picks. His nominee to lead the DEA, Terrance Cole, has previously voiced serious concerns about marijuana dangers and linked its use to higher suicide risk among youth. His HHS general counsel nominee, Mike Stuart, is so staunchly anti-cannabis that prohibitionist groups openly celebrated his selection.
Even Robert F. Kennedy Jr., who previously supported legalization, has walked back his stance since being confirmed as HHS Secretary, stating he’s “worried about” high-potency marijuana and deferring to the DEA on rescheduling.
When you stack the regulatory deck with cannabis skeptics, you’ve telegraphed your true intentions no matter what you said on the campaign trail.
Here’s what I’ve been saying all along: meaningful cannabis reform was never going to come from the White House, regardless of who occupied it. The DEA will never willingly relinquish its power, and politicians will always prioritize easier wins over controversial reforms.
The only real path forward is through Congress completely removing cannabis from the Controlled Substances Act. Full stop. No rescheduling, no administrative reviews, no half-measures. Cannabis needs to be descheduled entirely, returning regulatory authority to the states where it belongs.
But while we push for that goal, the real revolution continues on two fronts.
First, state-by-state legalization marches forward. Despite federal inaction, 38 states have medical marijuana programs, and 24 states plus DC have legalized adult use. Each new state that joins the ranks weakens prohibition’s grip and demonstrates the failure of federal policy.
Second, and perhaps more powerful, is what I call “mass defiance of an unjust law.” Every day, millions of Americans peacefully consume cannabis in direct violation of federal law. They grow it in their homes, share it with friends, and build communities around it. This civil disobedience at scale is perhaps the most effective weapon against prohibition.
The federal government simply doesn’t have the resources to enforce cannabis prohibition against a population that increasingly rejects it. When enough people break an unjust law, the law itself becomes unenforceable.
I hate to say I told you so, but… I told you so. The rescheduling promise was never going to materialize, regardless of who won the White House. It was a political mirage, designed to attract voters while requiring minimal commitment.
But don’t mistake my cynicism about federal action for pessimism about our cause. Cannabis reform is happening – it’s just happening from the ground up rather than the top down. Every state that legalizes, every municipality that decriminalizes, every voter who demands change, and yes, every person who peacefully consumes despite prohibition is part of this unstoppable movement.
The lesson here is simple: Don’t put your faith in presidential promises or administrative processes. Put it in your local ballot initiatives, your state legislators, and your own power to reject unjust laws through peaceful non-compliance.
Cannabis prohibition is dying, not because presidents commanded it, but because we the people have decided it must end. That’s the real power in our democracy – not the fleeting promises of politicians, but the sustained will of the citizens.
So next time a candidate promises to fix cannabis laws, remember this moment. Then go out and fix them yourself, one vote, one state, and one act of principled defiance at a time. That’s how real change happens in America, and that’s how we’ll finally end cannabis prohibition once and for all.
CANNABIS UNDER TRUMP 2.0, READ ON…
Cannabis News
Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place
Published
21 hours agoon
April 5, 2025By
admin
Quitting Won’t Fill the Hole
There’s a pervasive notion that floats around recovery circles—this idea that once you kick your habit, everything will magically fall into place. The clouds will part, the birds will sing, and suddenly life will be worth living again. While it’s true that being addicted to a “thing,” whether substance or act, eventually tallies up consequences that weigh heavy on our souls, the math isn’t quite as simple as “remove addiction, add happiness.”
I’ve watched countless cannabis enthusiasts (and addicts of all stripes) fall into this trap. They sit in circles, eyes gleaming with hope as they declare, “If I could only quit, then everything would be better…” But they’re missing something crucial—their addiction isn’t the source of their discontent; it’s merely a symptom of something deeper.
Addiction, at its core, is a means of dealing with something we cannot name or are desperately trying to avoid. It’s the bandage we slap over a wound without cleaning it first. The cannabis, the alcohol, the gambling, the endless scrolling—these aren’t the disease itself but rather the body’s misguided attempt at self-medication.
Here’s the uncomfortable truth that most recovery programs don’t emphasize enough: if you don’t do the real healing, even if you manage to white-knuckle your way through quitting one addiction, you’ll inevitably find something else to cover that gaping wound. Maybe you’ll trade joints for junk food, or bongs for binge-watching. The face of the addiction changes, but the role it plays remains constant.
Let’s take a deeper dive into this cycle and why simply quitting isn’t enough to truly heal.
First, we must acknowledge that when it comes to pain and addiction, everyone’s journey is unique. What feels like an insurmountable mountain to you might be a speed bump to someone else, and vice versa. There’s no universal scale for suffering, which makes navigating these waters all the more complex.
However, across all these varied experiences, there’s a common trap I’ve seen ensnare countless individuals—what I call the “If/Then Fallacy.” It’s the belief that one singular thing is the root cause of all our discomfort. This is where addicts often say, “If I can only kick this addiction, then my whole life would be better.” While this may seem logical on paper, it’s a deeply flawed perspective.
The real issue rarely lies with the substance or behavior itself but with something deeper—something the addiction is helping us avoid or cope with. Whether it’s trauma, depression, anxiety, or simply the existential weight of being human in an increasingly disconnected world, there’s usually a wound beneath the bandage.
Furthermore, the “If/Then” scenario places your healing, joy, and accomplishments in a fictional future state. “If I stop smoking weed, then I’ll finally have the motivation to start that business.” “If I quit drinking, then my relationship will improve.” These statements create a dangerous binary—because when the “if” is satisfied but the “then” doesn’t materialize, where does that leave you? Often, it leads to “If that didn’t work, then what’s the point of trying anything?”
This thinking creates a perfect setup for relapse or substituting one addiction for another. After all, if quitting didn’t magically transform your life as promised, why continue to deny yourself that temporary relief?
If you’ve been considering quitting cannabis or any other addiction, and you believe it to be the sole source of your unhappiness, I strongly urge you to reconsider your framework. The cannabis, or your relationship with it, is likely just a mask for your real pain. If you want to truly liberate yourself from the burden of addiction, you need to develop the capacity to sit with your pain, examine it, and cultivate joy despite it—not because it disappeared.
This article was inspired by a post I came across while scrolling through Reddit the other day—one of those moments where someone’s raw honesty stops you mid-scroll. A 32-year-old man shared that after smoking cannabis and drinking 4-6 beers daily for nearly his entire 20s, he had finally managed to quit both. No cannabis for almost six months, no alcohol for three. A significant achievement by any measure.
Yet instead of the transformation he expected, he felt “MISERABLE.” Despite taking medication for ADHD and anxiety, and despite removing substances that conventional wisdom says should improve his mental health, he felt no positive change. In fact, he felt worse, as if he’d “stopped doing things that were fun for me, or at least making life bearable.”
His post ended with a plea that broke my heart: “Is this just how I’m going to feel now? Does this go away eventually?”
This redditor’s experience perfectly illustrates the point—even when you manage to power through the physical and psychological challenges of quitting an addiction, your mental and spiritual state doesn’t necessarily transform as a result. His baseline remained exactly the same, perhaps even dipping lower without the chemical crutches he’d relied on for so long.
When you’re changing habits but not experiencing the promised benefits, it’s a clear sign that your discomfort or pain isn’t primarily coming from the substance. The cannabis or alcohol wasn’t creating your misery—it was masking it, providing temporary relief from a deeper issue that remains unaddressed.
This is something we all must consider when facing our compulsions. If you find yourself in a situation where you want to stop a behavior but simply can’t, it might be time to look deeper. Ask yourself, “Why do I do this activity?” And then ask “why” five more times, each answer digging a layer deeper toward the root cause.
Why do I smoke cannabis every night? Because it helps me relax. Why do I need help relaxing? Because my mind races with anxiety. Why does my mind race with anxiety? Because I’m worried about my future. Why am I worried about my future? Because I don’t feel secure in my career path. Why don’t I feel secure in my career path? Because I never really chose it—I fell into it. Why does that bother me? Because I feel like I’m not living authentically or pursuing my true passions.
Once you’ve excavated to this deeper level, you can begin to address the root causes directly. Perhaps the issue isn’t the cannabis at all, but rather that you need to reassess your career path or find meaning outside of work. Without this deeper work, quitting the substance becomes an exercise in willpower rather than healing.
Your addiction isn’t necessarily the root cause of your issues—it’s often just the most visible symptom. If you’re depressed, anxious, or feeling lost, it’s not primarily because of the substance; it’s because of something deeper that the substance helps you manage or forget temporarily.
Unless you actually do the internal work on these matters—examining your pain, seeking appropriate mental health support, rebuilding healthy relationships, finding meaning and purpose—no matter what you quit or how long you stay “clean,” you’ll likely find yourself seeking new ways to shield yourself from the pain. The prison isn’t cannabis or alcohol; it’s the unhealed wound those substances help you endure.
If you’re struggling right now, it’s absolutely important to seek help. That might mean therapy, support groups, or speaking with a healthcare provider about potential underlying mental health conditions that need treatment. But alongside that external support, commit to the honest and difficult work of looking inward. Ask yourself what you’re truly trying to avoid when you reach for that joint or that drink.
At the end of the day, we all have our struggles. If yours involves cannabis at this point in your life, there’s no judgment here. I’ve been there myself. But I’ve also learned that true healing rarely comes from simply removing something from your life—it comes from adding understanding, self-compassion, and addressing the real gaps in your heart and mind that the substance was never capable of filling in the first place.
The void can’t be filled by quitting. But quitting might just give you the clarity to finally see what the void truly needs.
QUITTING CANNABIS, READ ON…
THE STONER’S GUIDE TO QUITTING WEED – WAIT, WHAT…WHY?
Cannabis News
Scientists Now Think That One Compound in the Cannabis Plant Can Replace All Opiates
Published
3 days agoon
April 3, 2025By
admin
Which Cannabis Compound Do Scientists Think Can Replace Opiates?
…And Why This Is Important
Opiates are a type of pharmaceutical drug that’s been made from the opium poppy plant. While it’s somewhat a ‘natural’ substance that’s been extracted from the fibers and sap of the opium poppy plant, these are extremely dangerous sedatives that act on the central nervous system. However, there are completely synthetic opioids as well, which are manufactured entirely in laboratories.
Famous examples of well-known and widely-used opiates today include heroin, codeine, and morphine. They all work similarly, binding to the brain’s opioid receptors and users feel a drastic reduction in pain. It also causes users to feel euphoric, drowsy, or sleepy. Common side effects include constipation and nausea.
Because opiates are powerful for dulling one’s pain perceptions, they have become commonly prescribed by doctors and hospitals for pain relief. That said, opiates have become one of the world’s most addictive, dangerous, and fatal drugs – and you can get prescribed it right by your very own physician. Repeated use of opiates can easily lead to dependence and addiction, and eventually consuming high doses can drastically slow down breathing, and cause brain damage, or even death.
Since doctors still keep prescribing opioids, this has resulted in the deadly Opioid Epidemic, which has killed thousands of people. It’s a worrisome public health crisis, most especially because of fentanyl, an illegally manufactured opioid which is said to be 50 times more potent than heroin.
Could The Answer To The Opioid Epidemic Lie In Cannabis…Terpenes?
The past few years have shown that cannabis legalization is critical for surviving the opioid epidemic, and reducing overall opioid consumption.
The results of a recent research paper, which builds on past studies conducted by Dr. John Streicher, who is a member of the Comprehensive Center for Pain and Addiction, reveals fascinating findings. According to Streicher, cannabis terpenes were found to provide relief in inflammation models as well as on neuropathic pain caused by chemotherapy.
For the study, Streicher and his research team analyzed 4 kinds of terpenes that are found in mid to high levels in Cannabis sativa plants: linalool, geraniol, beta-caryophyllene, and alpha-humulene. They discovered that each terpene produced significant pain relief among mice subjects with fibromyalgia and post-operative pain, and among the terpenes, geraniol was found to be the most powerful.
“Our research is showing that terpenes are not a good option for reducing acute pain resulting from an injury, such as stubbing your toe or touching a hot stove; however, we are seeing significant reductions in pain when terpenes are used for chronic or pathological pain,” he said. “This study was the first to investigate the impact of terpenes in preclinical models of fibromyalgia and post-operative pain and expand the scope of potential pain-relieving treatments using terpenes,” Streicher said.
Cannabis terpenes are the compounds responsible for the aromatic profile of each strain; they are located in the plant trichomes. Not only do they contribute to each strain’s unique flavor and odor, but they also have valuable therapeutic and medicinal benefits. There are around 150 kinds of terpenes known today, though in the entire plant world, there are known to be some 20,000 terpenes.
Understanding the therapeutic benefits of terpenes is incredibly valuable also because they don’t contain THC (tetrahydrocannabinol), the compound in marijuana that gets you high.
“With fibromyalgia, there isn’t much of an understanding of what the pain state is, and there are not a lot of great options for treating it,” explains Streicher. “Our findings show that terpenes may be a viable treatment option for fibromyalgia pain, which could potentially have a large impact and make a difference for an under-treated population.”
Other Studies
This is not the first time that cannabis terpenes have been found to demonstrate excellent pain-relieving properties. It must be noted that just like what Streicher says, terpenes seem to do better with chronic pain management, instead of acute pain management.
Another study from 2024, which was published in The Journal of the Association for the Study of Pain, was conducted by researchers at the University of Arizona and the National Institutes of Health. The investigators analyzed the analgesic properties of different terpenes including geraniol, humulene, linalool, pinene, and caryophyllene among mice subjects with chemotherapy-induced peripheral neuropathy.
According to the researchers, all the terpenes delivered analgesic effects that were equivalent to around 10 mg/kg of morphine. It was also interesting to note that administering both morphine and terpenes together at low doses resulted in ‘enhanced’ pain-killing effects.
“Together these studies identify cannabis terpenes as potential therapeutics for chronic neuropathic pain,” said the investigators.
There have also been other studies that have found that combining cannabis with opioids can indeed provide long-lasting pain relief. It comes with the added benefit of reducing opioid doses needed for effective pain control. This phenomenon is called opioid-sparing. These types of protocols can be beneficial for patients who suffer from severe, chronic pain caused by cancer, arthritis, joint problems, fibromyalgia, diabetes, post-surgical pain, migraines, nerve damage, and so much more.
Conclusion
Learning more about the pain-killing properties of terpenes is extremely valuable for the medical community, patients, and even society as a whole. We can all do with less opioid addictions because it has torn families apart, and caused the deaths of thousands of people.
Terpenes, or cannabis in general, offer a natural and safe alternative that can be complementary to other pharmaceutical treatments designed to reduce pain.
SWAPPNG OPIOIDS FOR CANNABIS, READ ON…

Couple arrested with large amounts of weed and molly

The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!

Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place

Oklahoma voters could weigh in on adult-use marijuana legalization in 2026

Karma Koala Podcast 247: Speaking with Dr. Natalie Corthésy senior lecturer university of West Indies & Enrico Bonadio professor of law City St George’s University of London about their forthcoming Edward Elgar title, “Intellectual Property and Cannabis”

MJBizCon offers speakers chance to share cannabis insights, shape industry

The Best Tariff Friendly Cocktails

Cannabis Consumers Are Being Hit By The Tariffs

The Best Tips To Update Your Wardrobe

Former New York Knick Iman Shumpert debuts ‘TSA Approved’ legal cannabis brand

Distressed Cannabis Business Takeaways – Canna Law Blog™

United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)

What you Need to Know

Drug Testing for Marijuana – The Joint Blog

NCIA Write About Their Equity Scholarship Program

It has been a wild news week – here’s how CBD and weed can help you relax

Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022

A new April 20 cannabis contest includes a $40,000 purse

Your Go-To Source for Cannabis Logos and Designs

UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse